Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

TARSUS PHARMACEUTICALS INC (TARS)

240 + Investors. Track Smart Money conviction in TARS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +28
Streak
6Q ▲
Buyers last Q
56%

Smart Money Signals — TARS

Based on 245 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q
For 6 consecutive quarters, more hedge funds added TARS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
245 hedge funds hold TARS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +30% more funds vs a year ago

fund count last 6Q
+56 new funds entered over the past year (+30% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 56% buying

142 buying110 selling
Last quarter: 142 funds bought or added vs 110 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new TARS position: 38 → 43 → 36 → 54. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 33% long-term, 30% new

■ 33% conviction (2yr+) ■ 37% medium ■ 30% new
Of the 245 current holders: 80 (33%) held >2 years, 91 held 1–2 years, and 74 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Price up while funds trimmed (+36% value, -0% shares)

Value
+36%
Shares
0%
Last quarter: total value of institutional TARS holdings rose +36% even though funds reduced share count by 0%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
📈

Growing discovery — still being found

51 → 38 → 43 → 36 → 54 new funds/Q
New funds entering each quarter: 38 → 43 → 36 → 54. A growing number of institutions are discovering TARS each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
📊

Mixed cohorts — 39% veterans, 37% new entrants

■ 39% veterans ■ 23% 1-2yr ■ 37% new
Of 249 current holders: 98 (39%) held 2+ years, 58 held 1–2 years, 93 (37%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
50 of 245 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in TARS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.1
out of 10
Moderate Exit Risk
Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TARS

In 2025 Q4, 142 hedge funds were net buyers of TARS (54 opened a new position, 88 added to an existing one), while 110 reduced or exited (84 trimmed, 26 sold completely) — a 56% buyer ratio, indicating a slight buying edge. This marks 6 consecutive quarters of net institutional buying — a persistent conviction signal. 40% of total institutional value in TARS is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +28 funds (more new holders than closures). Total institutional holders: 245.

Hedge Fund Ownership: TARS

How many hedge funds hold TARS — quarterly history vs. share price
Quarterly hedge fund ownership of TARS vs. share price

Market Analysis: TARS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TARS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

46 top-rated funds 5 high-conviction
Consensus
7.3
/ 10
breadth
×
Elite
3.3
/ 10
conviction
Hedge Fund Positioning: TARS
2026 Q1 Stats Unlock in 1 days 240 + Investors

Track Smart Money conviction in TARS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 240 211 13.74%
13F Shares 44M 45M -1.48%
Total Value $3.58B $2.64B 35.5%
New Positions 53 34 +19
Increased Positions 87 61 +26
Closed Positions 26 24 +2
Reduced Positions 83 94 -11
Total Calls 4 4 -
Total Puts 1 1 -
PUT/CALL Ratio 0.25 0.25 Bullish

Statistics: TARS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

240 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TARS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of TARS — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Ally Bridge Group (NY) LLC 4.58% 80,859 $5.7M
2 TANG CAPITAL MANAGEMENT LLC 4.23% 1,188,624 $83.4M
3 Deep Track Capital, LP 4.12% 3,600,000 $252.5M
4 Paradigm Biocapital Advisors LP 3.67% 2,562,154 $179.7M
5 Tri Locum Partners LP 2.49% 252,588 $17.7M
6 RTW INVESTMENTS, LP 2.34% 3,346,025 $234.7M
7 GordonMD Global Investments LP 2.09% 42,680 $3.0M
8 MPM BioImpact LLC 1.79% 329,750 $23.1M
9 Sands Capital Alternatives, LLC 1.42% 85,000 $6.0M
10 Frazier Life Sciences Management, L.P. 1.32% 728,644 $51.1M
11 HighVista Strategies LLC 1.02% 52,464 $3.7M
12 Rock Springs Capital Management LP 0.93% 225,179 $15.8M
13 Cormorant Asset Management, LP 0.79% 225,000 $15.8M
14 Lisanti Capital Growth, LLC 0.74% 41,815 $2.9M
15 SECTORAL ASSET MANAGEMENT INC 0.71% 11,272 $852K
16 Integral Health Asset Management, LLC 0.67% 200,000 $14.0M
17 BRAIDWELL LP 0.62% 265,715 $18.6M
18 PFM Health Sciences, LP 0.51% 80,226 $5.6M
19 Verdad Advisers, LP 0.50% 6,328 $444K
20 DRIEHAUS CAPITAL MANAGEMENT LLC 0.48% 926,125 $65.0M
21 TimesSquare Capital Management, LLC 0.46% 388,590 $27K
22 Seven Fleet Capital Management LP 0.44% 19,800 $1.4M
23 Vestal Point Capital, LP 0.39% 200,000 $14.0M
24 VARCOV Co. 0.39% 14,875 $1.0M
25 Odyssean, LLC 0.35% 13,737 $964K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — TARSUS PHARMACEUTICALS INC (TARS)

What does the Smart Money Trend signal show for TARS?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added TARS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TARS?

Slight buying edge — 56% buying: Last quarter: 142 funds bought or added vs 110 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TARS holders?

Elite ownership — 40% AUM from top-100 funds: 50 of 245 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in TARS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held TARS?

Mixed — 33% long-term, 30% new: Of the 245 current holders: 80 (33%) held >2 years, 91 held 1–2 years, and 74 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.